International investment fund Carlyle Group has confirmed in a press release the purchase of a majority stake in the Czech Meopta-optika (known simply as Meopta) company, which manufactures optical products for various uses.
The U.S.-based investment first will take over Meopta – founded 90 years ago – for about CZK 16 billion. The transaction is subject to regulation and is expected to be completed this year.
PARTNER ARTICLE
Meopota produces optical and optoelectronic items for military, industrial, and consumer purposes. Some of the products that it manufactures are binoculars, enlargers, and film cameras.
Meopta CEO Alena Moore“We believe Carlyle is an ideal partner for Meopta on the next stage of our journey, with its deep experience in our industry and track record in the growth and internationalization of leading European technology businesses”
Clearly expanding
The Meopta site, based in the Olomouc region, includes 140,000 square meters of production space and employs over 1,700 people. According to current majority Meopta shareholder Gerald Rausnitz, the firm has become a leader in optical, optomechanical, and optoelectronic solutions.
In 2021, Meopta reported a record net profit of CZK 806.4 million – a year-on-year increase of almost 800 percent. Its total revenue that year was around CZK 3.7 billion; annual sales increased by CZK 1 billion crowns and were the highest in the company's history. Better sales were mainly due to increased global demand for optoelectronics and chips used in the semiconductor industry.

The managing director of the investment advisory team at Carlyle Friedel Drees said that Meopta “offers world-class expertise in the design, manufacture, assembly, and testing of optical components and systems," adding that it was "well-positioned to benefit from strong secular tailwinds.”
Carlyle's Czech movements
In Czechia, Carlyle owns the Phrase (formerly known as Memsource) start-up, which develops a cloud platform for automation and improves the efficiency of language translations. This deal was announced in 2020, when the company was labeled as one of the top 50 fastest-growing IT companies in Czechia.
In late 2022, Carlyle also announced its plans to acquire a majority stake in Czech firm Tescan, which produces electron microscopes and other high-tech scientific instruments, such as 4D scanning. Carlyle has an estimated USD 376 billion (over CZK 8.3 trillion) of assets under management and in 2022 was the world’s sixth-largest private equity firm raised by capital.